Rollover Study From EXG-US-01
Rollover Study From EXG-US-01
Enrolling by invitation · NCT05868499 · Registry updated 2024-07-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rollover Study From EXG-US-01 | Telomere Biology Disorders With Bone Marrow Failure | Enrolling by invitation | Phase 1 | 2024-07-12 | NCT05868499 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elixirgen Therapeutics, Inc. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Children's Hospital | Cincinnati | United States | 66 |